The latest cancer drugs news
Browsing: Cancer Drug News
NICE recommends dabrafenib plus trametinib combo for treating BRAF V600E mutation-positive brain tumours
Novartis announced today that the National Institute for Health and Care Excellence has published its Final Draft…
A closed-loop drug-delivery system could improve chemotherapy
When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the…
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer
On April 18, 2024, the Food and Drug Administration approved alectinib for adjuvant treatment following…
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, to be…
Assessment of clinical benefit in recent FDA accelerated approvals for cancer drugs
The process of accelerated approval by the US Food and Drug Administration (FDA) has been…
Colorectal cancer gene implicated in broad range of solid tumours
A gene associated with colorectal cancer appears to also play a role in the development…
FDA approves mirvetuximab soravtansine-gynx for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
On March 22, 2024, the Food and Drug Administration approved mirvetuximab soravtansine-gynx for adult patients…
FDA grants accelerated approval to ponatinib with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia
On March 19, 2024, the Food and Drug Administration granted accelerated approval to ponatinib (Iclusig,…
Relugolix results for prostate cancer treatment with radiation therapy
A high impact study led by Daniel Spratt, M.D., University Hospitals Seidman Cancer Center, USA,…
FDA approves amivantamab-vmjw for EGFR exon 20 insertion-mutated non-small cell lung cancer indications
On March 1, 2024, the Food and Drug Administration approved amivantamab-vmjw with carboplatin and pemetrexed…